We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generic Industry to Reconsider User Fees on ANDAs
Generic Industry to Reconsider User Fees on ANDAs
May 27, 2005
The Generic Pharmaceutical Association (GPhA) said it plans to take a close look at whether user fees would be appropriate for the generic drug industry — an inquiry that was requested by a House lawmaker.